Marit J. Van Elsas
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer.
Journal: Nature immunology
Published: October 28, 2024
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumors.
Journal: Nature communications
Published: March 04, 2024
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery.
Journal: Nature
Published: December 14, 2023
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy.
Journal: Cancer cell
Published: September 29, 2023
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.
Journal: Science immunology
Published: May 19, 2023
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: February 21, 2023
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.
Journal: International journal of molecular sciences
Published: June 24, 2022
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
Journal: International journal of cancer
Published: August 26, 2021
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.
Journal: Journal for immunotherapy of cancer
Published: March 25, 2021
Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models.
Journal: Journal for immunotherapy of cancer
Published: August 27, 2020
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: August 06, 2020
Last Updated: 09/26/2026